跳至主要内容
临床试验/NCT07515664
NCT07515664招募中4 期

Vitamin K Reversal of INR for Perioperative Management of Warfarin: : A Pilot Study to Assess Feasibility

University of Michigan1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年7月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
20
试验地点
1
主要终点
Feasibility of patient recruitment

研究概览

简要总结

This is a feasibility study of uninterrupted warfarin with a one time dose of Vitamin K before a surgical procedure.

详细描述

Historically, warfarin is held for 5 days before a surgical procedure to obtain a safe INR (international normalized ratio) that minimizes bleeding risk. However, there is a strong rationale for continuing warfarin uninterrupted in the perioperative space and giving a one-time vitamin K dose to get a safe INR pre-operatively. This feasibility study will recruit patients who use warfarin and will measure their INR response after receiving a single pre-procedure vitamin K dose. This study will also assess the use of a one-time "loading" dose immediately post-operative to help the INR return to the therapeutic range sooner than continuing with the standard warfarin dosing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Warfarin therapy for ≥3 months
  • Use of home INR testing equipment
  • Scheduled for a surgical procedure that requires INR ≤ 1.5 (typically achieved with warfarin interruption)
  • INR ≤ 4 on day 7-10 prior to procedure

排除标准

  • Surgical procedure does not require INR ≤1.5 (typically achieved with warfarin interruption)
  • Surgical procedure with a high risk of bleeding or complications (urologic procedures, bronchoscopy, epidural injections, nerve blocks, spinal surgery)
  • Warfarin therapy for < 3 months
  • Lack of English language proficiency
  • Use of a Heartmate II or HVAD left ventricular assist device
  • Recent thrombotic event (within 3 months)
  • CHA2DS2-VASc score >6
  • INR >4 on day 7-10 prior to procedure
  • Hypersensitivity to any component of Vitamin K or simple syrup (used in the compounding process)

研究组 & 干预措施

Standard Warfarin Dosing with Vitamin K

Experimental

Patients will receive their standard warfarin dosing before, during, and after their procedure. This is in addition to a one time dose of oral vitamin K pre-procedure.

干预措施: Warfarin (standard without loading) (Drug)

Loading Warfarin Dosing with Vitamin K

Experimental

Patients will receive their standard warfarin dosing before and during their procedure. On the night following the procedure, they will receive a one time loading dose of warfarin (twice their normal dose). Patients will then resume normal dosing of warfarin. This is in addition to a one time dose of oral vitamin K pre-procedure.

干预措施: Warfarin (standard with loading) (Drug)

Loading Warfarin Dosing with Vitamin K

Experimental

Patients will receive their standard warfarin dosing before and during their procedure. On the night following the procedure, they will receive a one time loading dose of warfarin (twice their normal dose). Patients will then resume normal dosing of warfarin. This is in addition to a one time dose of oral vitamin K pre-procedure.

干预措施: Vitamin K (Drug)

Standard Warfarin Dosing with Vitamin K

Experimental

Patients will receive their standard warfarin dosing before, during, and after their procedure. This is in addition to a one time dose of oral vitamin K pre-procedure.

干预措施: Vitamin K (Drug)

结局指标

主要结局

Feasibility of patient recruitment

时间窗: Within two weeks (from outreach to five days prior to procedure)

Percentage of recruited patients among those initially screened

INR reversal

时间窗: Within 12 hours prior to procedure

Percentage of enrolled patients with an INR less than or equal to 1.5 on morning of procedure

次要结局

  • Fidelity to intervention protocol(12 day span from 2 days pre-operative through 10 days post-operative)
  • Fidelity to randomization(24 hours (day of procedure))
  • Cost per recruited patient(12 day span from 2 days pre-operative through 10 days post-operative)
  • Patient acceptability(10 days post procedure)
  • Clinical acceptability(10 days post procedure)
  • Therapeutic INR by post-operative day 5(day 5 post procedure)
  • Adverse events(30 days post procedure)
  • Canceled procedures(24 hours prior to procedure)
  • Additional warfarin reversal pre-operative(24 hours pre-procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Geoffrey Barnes

Associate Professor of Internal Medicine

University of Michigan

研究点 (1)

Loading locations...

相似试验